An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein

Since the first appearance of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2) in China on December 2019, the world has now witnessed the emergence of the SARS- CoV-2 outbreak. Therefore, due to the high transmissibility rate of virus, there is an urgent need to design and develop v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafouri, Fatemeh, Cohan, Reza Ahangari, Noorbakhsh, Farshid, Samimi, Hilda, Haghpanah, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336711/
https://www.ncbi.nlm.nih.gov/pubmed/32702713
http://dx.doi.org/10.21203/rs.3.rs-30374/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336711/
https://www.ncbi.nlm.nih.gov/pubmed/32702713
http://dx.doi.org/10.21203/rs.3.rs-30374/v1

Ejemplares similares